Patents by Inventor Ann Newman

Ann Newman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 18-MC SALT FORMS
    Publication number: 20230303572
    Abstract: A composition including a salt of 18-MC, wherein the salt is chosen from gentisate, hydrobromide, besylate, napadisylate, hydrochloride, sulfate, oxalate, maleate, mesylate, and tosylate. A composition including a polymorph of 18-MC.
    Type: Application
    Filed: March 1, 2023
    Publication date: September 28, 2023
    Applicant: Mind Medicine, Inc.
    Inventors: Jeanne BONELLE, Daniel Emil LEVY, Ann NEWMAN, Stephen E. SCHNEIDER
  • Gatifloxacin pentahydrate
    Patent number: 6413969
    Abstract: There are provided in accordance with the present invention crystalline gatifloxacin pentahydrate represented by the formula in a highly homogeneous form with respect to other crystalline forms thereof.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: July 2, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Krishnaswamy S. Raghavan, Sunanda A. Ranadive, Jack Z. Gougoutas, John D. DiMarco, William L. Parker, Martha Davidovich, Ann Newman
  • Gatifloxacin pentahydrate
    Publication number: 20020052379
    Abstract: There are provided in accordance with the present invention crystalline gatifloxacin pentahydrate represented by the formula 1
    Type: Application
    Filed: August 17, 2001
    Publication date: May 2, 2002
    Inventors: Krishnaswamy S. Raghavan, Sunanda A. Ranadive, Jack Z. Gougoutas, John D. DiMarco, William L. Parker, Martha Davidovich, Ann Newman